Tags Reports - Allied Market Research

sale

DNA Vaccine Market

P

2021

DNA Vaccine Market: Global Opportunity Analysis and Industry Forecast, 2021–2030.

The global DNA vaccine market size was valued at $422.77 Million in 2020 and is projected to reach $774.43 Million by 2030 registering a CAGR of 6.3% from ...

Report Code : A00549 | Pages : 123 | Category : Life Sciences

Price:

~~$3,712~~ $2,784 (25% Off)

License: Cloud Access

PDF, PPT, XLS

UPDATE AVAILABLE ON DEMAND

sale

Single-use Bioprocessing Market

P

2022

Single-use Bioprocessing Market: Global Opportunity Analysis and Industry Forecast, 2020 - 2030

The report focuses on the major industry players operating in the Turkey Single-use Bioprocessing Market and their relative market share. End User segment dominates the Turkey Single-use Bioprocessing Market and is expected to retain its dominance throughout the forecast period.

Report Code : A02028 | Pages : 200 | Category : Life Sciences

Price:

~~$3,570~~ $2,499 (30% Off)

License: Cloud Access

PDF, PPT, XLS

UPDATE AVAILABLE ON DEMAND

sale

Mixed Mode Chromatography Resin Market

U

2025

Mixed Mode Chromatography Resin Market: Global Opportunity Analysis and Industry Forecast, 2023-2032

Mixed mode chromatography resin is defined as an interaction or mixed-mode media used in the chromatographic method. Mixed mode chromatography contains ligands of multimodal functionality that allow protein ...

Report Code : A15953 | Category : Materials and Chemicals

Price:

~~$3,690~~ $2,583 (30% Off)

License: Cloud Access

PDF, PPT, XLS

sale

Newcastle Disease Vaccine Market by Vaccine Type

P

2024

Newcastle Disease Vaccine Market by Vaccine Type : Global Opportunity Analysis and Industry Forecast, 2024 - 2033

The global newcastle disease vaccine market was valued at $0.4 billion in 2023, and is projected to reach $0.6 billion by 2033, growing at a CAGR of 4.4% from 2024 to 2033.

Report Code : A324484 | Pages : 216 | Category : Life Sciences

Price:

~~$2,655~~ $1,859 (30% Off)

License: Cloud Access

PDF, PPT, XLS

UPDATE AVAILABLE ON DEMAND

sale

Downstream Processing Market

P

2022

Downstream Processing Market: Global Opportunity Analysis and Industry Forecast, 2020-2030

The global downstream processing market was valued at $21.8 billion in 2020, and is projected to reach $92.0 billion by 2030, growing at a CAGR of 13.5% from 2021 to 2030.

Report Code : A02527 | Pages : 256 | Category : Life Sciences

Price:

~~$3,456~~ $2,419 (30% Off)

License: Cloud Access

PDF, PPT, XLS

UPDATE AVAILABLE ON DEMAND

sale

Veterinary Vaccine Adjuvants Market

P

2024

Veterinary Vaccine Adjuvants Market: Global Opportunity Analysis and Industry Forecast, 2024 - 2033

The global veterinary vaccine adjuvants market was valued at $0.4 billion in 2023, and is projected to reach $0.6 Billion by 2033, growing at a CAGR of 4.6% from 2024 to 2033

Report Code : A324537 | Pages : 280 | Category : Life Sciences

Price:

~~$2,655~~ $1,859 (30% Off)

License: Cloud Access

PDF, PPT, XLS

UPDATE AVAILABLE ON DEMAND

sale

Australia Vaccines Market

P

2024

Australia Vaccines Market: Opportunity Analysis and Industry Forecast, 2024 - 2033

The Australia vaccines market was valued at $0.6 billion in 2023, and is projected to reach $1.2 billion by 2033, growing at a CAGR of 7.2% from 2024 to 2033.

Report Code : A325353 | Pages : 90 | Category : Life Sciences

Price:

~~$1,859~~ $1,301 (30% Off)

License: Cloud Access

PDF, PPT, XLS

UPDATE AVAILABLE ON DEMAND

sale

U.S. Vaccines Market

P

2024

U.S. Vaccines Market: Opportunity Analysis and Industry Forecast, 2024 - 2033

The U.S. vaccines market was valued at $16.4 billion in 2023, and is projected to reach $29.1 billion by 2033, growing at a CAGR of 5.9% from 2024 to 2033.

Report Code : A325351 | Pages : 90 | Category : Life Sciences

Price:

~~$2,177~~ $1,524 (30% Off)

License: Cloud Access

PDF, PPT, XLS

UPDATE AVAILABLE ON DEMAND

sale

North America Vaccines Market

P

2024

North America Vaccines Market: Opportunity Analysis and Industry Forecast, 2024 - 2033

The North America vaccines market was valued at $18.0 billion in 2023, and is projected to reach $32.1 billion by 2033, growing at a CAGR of 5.9% from 2024 to 2033.

Report Code : A325348 | Pages : 110 | Category : Life Sciences

Price:

~~$2,443~~ $1,710 (30% Off)

License: Cloud Access

PDF, PPT, XLS

UPDATE AVAILABLE ON DEMAND

Results for Tags: vaccine

Filter by Region

Filter by Discounts

Filter by Category

The global DNA vaccine market size was valued at $422.77 Million in 2020 and is projected to reach $774.43 Million by 2030 registering a CAGR of 6.3% from ...

The report focuses on the major industry players operating in the Turkey Single-use Bioprocessing Market and their relative market share. End User segment dominates the Turkey Single-use Bioprocessing Market and is expected to retain its dominance throughout the forecast period.

Mixed mode chromatography resin is defined as an interaction or mixed-mode media used in the chromatographic method. Mixed mode chromatography contains ligands of multimodal functionality that allow protein ...

The global newcastle disease vaccine market was valued at $0.4 billion in 2023, and is projected to reach $0.6 billion by 2033, growing at a CAGR of 4.4% from 2024 to 2033.

The global downstream processing market was valued at $21.8 billion in 2020, and is projected to reach $92.0 billion by 2030, growing at a CAGR of 13.5% from 2021 to 2030.

The global veterinary vaccine adjuvants market was valued at $0.4 billion in 2023, and is projected to reach $0.6 Billion by 2033, growing at a CAGR of 4.6% from 2024 to 2033

The Australia vaccines market was valued at $0.6 billion in 2023, and is projected to reach $1.2 billion by 2033, growing at a CAGR of 7.2% from 2024 to 2033.

The U.S. vaccines market was valued at $16.4 billion in 2023, and is projected to reach $29.1 billion by 2033, growing at a CAGR of 5.9% from 2024 to 2033.

The North America vaccines market was valued at $18.0 billion in 2023, and is projected to reach $32.1 billion by 2033, growing at a CAGR of 5.9% from 2024 to 2033.